BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30

Basel Medical Group Ltd

Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 18, 2025

$4.05+0.10 (+2.53%)

Close on Oct 19, 2026

Basel Medical Group Ltd income statement

AnnualQuarterlyTTM

Millions of SGD, except per-share data. Shares in millions.

Line item	FY 2025 2025-06-30	FY 2024 2024-06-30
Revenue	11	10
Selling & Marketing	0.61	0.70
Interest Expense	0.20	0.18
Pretax Income	-11	2.40
Income Tax Expense	-0.42	0.33
Net Income incl. Noncontrolling Interests	-11	2.07
Minority Interest in Earnings	0.00	–
Net Income	-11	2.07
EPS (Basic)(per share)	-0.64	0.13
EPS (Diluted)(per share)	-0.57	0.13
Shares Outstanding (Basic, Weighted)(shares)	19	16
Shares Outstanding (Diluted, Weighted)(shares)	19	16

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: –
Operating margin: –
Net margin: -94.0%
Return on equity, FY2025: –

Financial strength

Current ratio: 1.88
Debt to equity: –
Debt to assets: 74.7%
Cash to current liabilities: 17.9%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.